-
Webinar: IVDR in the laboratory routine – how to make the transition successfully?
Join us for our webinar on the European In Vitro Diagnostics Regulation (IVDR) on Thursday, May 25 at 17:00 CEST. Register for free here.
-
Overcoming IVDR Challenges – A Webinar on November 8, 2022, at 18:00 CET
Join a unique virtual event examining the relevance of the new European In-Vitro Diagnostics Medical Device Regulation (EU)2017/746 (IVDR) for clinical laboratories. We share our experience in gaining IVDR certification for our clinical decision support solution MH Guide to give you a leg up. We hope to see you for this free-to-attend webinar on November 8th, 2022, at 18:00 CET. Click here to register.
-
Webinar: Deepen your knowledge on comprehensive genomic profiling
Join our educational webinar on comprehensive genomic profiling on Wednesday, October 5 at 6:00 PM CEST, to find out how your cancer patient can benefit from biomarker testing. Register for free https://event.on24.com/wcc/r/3923804/7192787FC3EE75423B64180F985FE7B5
-
MH Guide Webinar – 07.06.2022 12:00 am EST
Join our free-to-attend Live Webinar showcasing how MH Guide translates genomic tumor data into clinical evidence in a few minutes.
-
MH Guide 5.2 – Improved focus. Greater flexibility. Better usability.
When it comes to targeted cancer treatments, new biomarkers are continually found, and additional treatment options are approved. Keeping pace with those changes with MH Guide 5.2.
-
MH Guide Webinar – 28.04.2022 5:00 pm CET
Join our free-to-attend Live Webinar showcasing how to automatically identify clinically actionable biomarkers in molecular tumor profiles of individual patients.
-
Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions
Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ2 published a triad of articles that describe and prove the concept of a novel systems approach to elucidate molecular mechanisms of drug toxicities using real-world data (RWD).
-
What’s new in MH Guide 5.1
The MH Guide 5.1 upgrade introduces new features and improved capabilities to access more information and make therapy decisions clearer.
-
Molecular Health and Gen Era Diagnostics agree to collaborate in the field of precision oncology in Turkey
Molecular Health and the life science company Gen Era Diagnostics have signed a collaboration agreement to optimize the personalized treatment of patients with cancer. For this purpose, Gen Era will provide the MH Guide software platform to twenty laboratories in Turkey to use in the interpretation of tumor data.
-
The potential of liquid biopsies for early cancer detection powered by ONCOCATCH and MH Guide
Molecular Health will join partner EONE-Diagnomics Genome Center (EDGC) in the EDGC seminar “Liquid biopsy for early detection of multiple cancers and Molecular Health GmbH introduction” on Wednesday, 13 October at 16:00–17:00 Korean Standard Time (GMT+9).